Optum notable drugs nearing FDA approval include Anaphylm, Sotyktu, and insulin icodec with decisions expected early 2026.
Senators are calling UnitedHealth Group’s response to an investigation "inadequate" and demanding more information following ...
With a market cap of $294.2 billion, UnitedHealth Group Incorporated (UNH) is a diversified health care company operating in the United States and internationally through four segments: ...
A contract termination between Optum and Humana, as well as the expiration of enhanced tax credits for people covered by Affordable Care Act, went into effect Jan. 1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback